Emerging experience with meningococcal serogroup B protein vaccines

Emerging experience with meningococcal serogroup B protein vaccines

Introduction: The successful development of two broadly protective vaccines targeting Neisseria meningitidis serogroup B (MenB); 4CMenB and rLP2086, is the most significant recent advance in meningococcal disease prevention. Areas covered: Here we review the principles underlying the development of...

Full description

Bibliographic Details
Main Authors:	Daniela Toneatto, Mariagrazia Pizza, Vega Masignani, Rino Rappuoli
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-05-01
Series:	Expert Review of Vaccines
Subjects:	4cmenb carriage immunogenicity mats measure meningococcal serogroup b neisseria meningitidis reverse vaccinology rlp2086 strain coverage
Online Access:	http://dx.doi.org/10.1080/14760584.2017.1308828

Similar Items

Meningococcal B vaccine (4CMenB): the journey from research to real world experience
by: Rino Rappuoli, et al.
Published: (2018-12-01)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
by: Robert G. K. Donald, et al.
Published: (2017-02-01)

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS
by: Sarah J. Tozer, et al.
Published: (2021-09-01)

The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
by: Vega Masignani, et al.
Published: (2019-04-01)

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
by: Federico Martinón-Torres, et al.
Published: (2019-12-01)

Vaccines against Meningococcal Diseases
by: Mariagrazia Pizza, et al.
Published: (2020-10-01)

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269
by: Maria Stella, et al.
Published: (2020-04-01)

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021-12-01)

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine
by: John L. Perez, et al.
Published: (2018-06-01)

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018-05-01)

Fatal meningococcal meningitis in a HIV-infected patient caused by serogroup C Neisseria meningitidis belonging to the non-hypervirulent clonal complex ST-60 (cc60)
by: Claudia Ferreira de Andrade, et al.

Meningococcal vaccines: past, present, and future perspectives
by: Seyed Davar Siadat and Dariush Norouzian
Published: (2007-10-01)

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
by: Kylie S. Carville, et al.
Published: (2016-10-01)

A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions
by: Luciana Andrea Digieri Chicuto, et al.
Published: (2020-08-01)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
by: Alessia Biolchi, et al.
Published: (2019-03-01)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
by: Marco Aurelio Palazzi Sáfadi, et al.
Published: (2014-05-01)

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
by: Nan-Chang Chiu, et al.
Published: (2018-05-01)

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature
by: Paul Balmer, et al.
Published: (2018-05-01)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
by: George Kassianos, et al.
Published: (2023-07-01)

Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis
by: Wilfrido Coronell-Rodriguez, et al.
Published: (2023-11-01)

Nasopharyngeal Meningococcal Carriage among Children and Adolescents in Turkey in 2018: An Unexpected High Serogroup X Carriage
by: Mahmut Can Kizil, et al.
Published: (2021-09-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
by: David E Barroso, et al.
Published: (2007-09-01)

Meningococcal Disease in South Africa, 1999–2002
by: Garry B. Coulson, et al.
Published: (2007-02-01)

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
by: Dang Vica, et al.
Published: (2012-08-01)

Neisseria meningitidis Serogroup X Sequence Type 2888, Italy
by: Cecilia Fazio, et al.
Published: (2010-02-01)

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland
by: Margherita Bodini, et al.
Published: (2020-10-01)

CC4821 serogroup W meningococcal disease in China
by: Baohua He, et al.
Published: (2014-12-01)

Meningococcal Carriage in ‘Men Having Sex With Men’ With Pharyngeal Gonorrhoea
by: Sara Morselli, et al.
Published: (2022-01-01)

An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia
by: Kim Soon, et al.
Published: (2012-11-01)

Triplex Real-Time PCR without DNA Extraction for the Monitoring of Meningococcal Disease
by: Melissa J. Whaley, et al.
Published: (2018-08-01)

Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
by: Judith E. Mueller, et al.
Published: (2007-06-01)

A severe course of serogroup W meningococcemia in a patient with infantile nephropathic cystinosis
by: Gurkan Bozan, et al.
Published: (2020-11-01)

Primary meningococcal arthritis of the hip due to serogroup W in a pediatric patient
by: Gabriel Dapueto, et al.
Published: (2021-01-01)

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)
by: Gary S. Marshall, et al.
Published: (2023-12-01)

Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling study
by: Matthieu Domenech de Cellès, et al.
Published: (2020-04-01)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
by: Emilija Sereikaitė, et al.
Published: (2023-02-01)

MENINGOCOCCAL SEPSIS – CASE REPORT
by: Andreja Cokan, et al.
Published: (2002-01-01)

Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
by: Jane Whelan, et al.
Published: (2016-06-01)

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland
by: Robert M. Mulhall, et al.
Published: (2018-08-01)

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
by: Ray Borrow, et al.
Published: (2017-04-01)